Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jeremiah W. Bertz"'
Autor:
Jeremiah W. Bertz, Kirsten E. Smith, Leigh V. Panlilio, Samuel W. Stull, David Reamer, Marie-Louise Murville, Michael Sullivan, August F. Holtyn, Forrest Toegel, David H. Epstein, Karran A. Phillips, Kenzie L. Preston
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 1, Iss , Pp 100011- (2021)
Background: Employment and improved quality of life (QOL) are, separately, valued outcomes of substance use disorder (SUD) treatment. It is also important to understand QOL changes caused by employment itself; therefore, we assessed QOL during a rand
Externí odkaz:
https://doaj.org/article/3dce7b3991d34303add9cac5431751c3
Autor:
Emre Ertin, Nithin Sugavanam, August F. Holtyn, Kenzie L. Preston, Jeremiah W. Bertz, Lisa A. Marsch, Bethany McLeman, Dikla Shmueli-Blumberg, Julia Collins, Jacqueline S. King, Jennifer McCormack, Udi E. Ghitza
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
As digital technology increasingly informs clinical trials, novel ways to collect study data in the natural field setting have the potential to enhance the richness of research data. Cocaine use in clinical trials is usually collected via self-report
Externí odkaz:
https://doaj.org/article/a432087d55b744c983808f73309ba81f
Autor:
R. Benjamin Free, Ashley N. Nilson, Noelia M. Boldizsar, Trevor B. Doyle, Ramona M. Rodriguiz, Vladimir M. Pogorelov, Mayako Machino, Kuo Hao Lee, Jeremiah W. Bertz, Jinbin Xu, Herman D. Lim, Andrés E. Dulcey, Robert H. Mach, James H. Woods, J Robert Lane, Lei Shi, Juan J. Marugan, William C. Wetsel, David R. Sibley
Publikováno v:
ACS Pharmacology & Translational Science. 6:151-170
Autor:
R. Benjamin Free, Ashley N. Nilson, Noelia M. Boldizsar, Trevor B. Doyle, Ramona M. Rodriguiz, Vladimir M. Pogorelov, Mayako Machino, Kuo Hao Lee, Jeremiah W. Bertz, Jinbin Xu, Herman D. Lim, Andrés E. Dulcey, Robert H. Mach, James H. Woods, J Robert Lane, Lei Shi, Juan J. Marugan, William C. Wetsel, David R. Sibley
We have developed and characterized a novel D2R antagonist with exceptional GPCR selectivity – ML321. In functional profiling screens of 168 different GPCRs, ML321 showed little activity beyond potent inhibition of the D2R, and to a lesser extent t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a0f9a844dff00ad9e58ab05b7c6477
https://doi.org/10.1101/2022.11.14.516475
https://doi.org/10.1101/2022.11.14.516475
Autor:
Samuel W. Stull, Jacqueline Mogle, Jeremiah W. Bertz, Albert J. Burgess-Hull, Leigh V. Panlilio, Stephanie T. Lanza, Kenzie L. Preston, David H. Epstein
Publikováno v:
Psychological assessment. 34(10)
In intensive longitudinal studies using ecological momentary assessment, mood is typically assessed by repeatedly obtaining ratings for a large set of adjectives. Summarizing and analyzing these mood data can be problematic because the reliability an
Autor:
Massoud Vahabzadeh, Patrick H. Finan, David H. Epstein, Karran A. Phillips, Jeremiah W. Bertz, Kenzie L. Preston, Leigh V. Panlilio, Samuel W. Stull, William J. Kowalczyk, Landhing M. Moran, Jia-Ling Lin
Publikováno v:
J Abnorm Psychol
Anhedonia is usually defined as partial or total loss of the capacity for pleasure. People with anhedonia in the context of major depressive disorder may have an unexpected capacity for event-related mood brightening, observable when mood is assessed
Autor:
Jeremiah W. Bertz, Leigh V. Panlilio, Samuel W. Stull, Kirsten E. Smith, David Reamer, August F. Holtyn, Forrest Toegel, William J. Kowalczyk, Karran A. Phillips, David H. Epstein, Kenneth Silverman, Kenzie L. Preston
Publikováno v:
Behav Res Ther
Employment problems are common among people with substance use disorders (SUDs), and improving vocational functioning is an important aspect of SUD treatment. More detailed understanding of the psychosocial benefits of employment may help refine voca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef0beb0c264de03d7ce42ae8cc6fed1
https://europepmc.org/articles/PMC9206864/
https://europepmc.org/articles/PMC9206864/
Autor:
Karran A. Phillips, David H. Epstein, Samuel W. Stull, William J. Kowalczyk, Leigh V. Panlilio, Kenzie L. Preston, Jeremiah W. Bertz, Albert J. Burgess-Hull
Publikováno v:
Psychopharmacology (Berl)
RATIONALE: Many people being treated for opioid use disorder continue to use drugs during treatment. This use occurs in patterns that rarely conform to well-defined cycles of abstinence and relapse. Systematic identification and evaluation of these p
Publikováno v:
J Addict Med
Objectives Anhedonia can accompany substance use disorders (SUDs); its severity may vary by substance type, severity of SUD symptoms, or psychiatric comorbidity. The goal of this study was to clarify the contribution of each. Methods Data were from p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64d3074343b32944c46fe309f5b2e180
https://europepmc.org/articles/PMC8761228/
https://europepmc.org/articles/PMC8761228/
Autor:
Michelle L. Jobes, William J. Kowalczyk, Greg Ward, Ashley P. Kennedy, Barbara Plitnick, David A. Reamer, Jeremiah W. Bertz, Kenzie L. Preston, Mark S. Rea, Mariana G. Figueiro, Karran A. Phillips, David H. Epstein
Publikováno v:
J Subst Abuse Treat
Sleep problems are commonly reported during opioid agonist treatment (OAT) for opioid use disorders. Inpatient studies have found both sleep disturbances and improved sleep during OAT. Illicit opioids can also disrupt sleep, but it is unclear how the